Document is current
Any future updates will be listed below
-
Authors
Vizza, Lisa
Maher, Christopher G.
Ivers, Rowena
McLachlan, Andrew J.
Kelly, Patrick J.
Blyth, Fiona
Clare, Philip James
Thompson, Rachel
Lung, Thomas
Degenhardt, Louisa
Reid, Sharon
Martin, Bradley C.
Wright, Michael
Osman, Rawa
French, Simon D.
McCaffery, Kirsten J.
Campbell, Gabrielle
Jenkins, Hazel J.
Mathieson, Stephanie
Boogs, Monika
McMaugh, Jarrod
Bennett, Carol
Stanaway, Fiona
Abdel Shaheed, Christina https://orcid.org/0000-0003-1258-5125
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 19 April 2025
First Online: 17 June 2025
Declarations
:
: Ethics approval has been received by The University of Sydney (2023/632).
: No separate consent for publication is required. The results for the SWAT will be de-identified.
: The Sydney Pharmacy School receives funding for a postgraduate scholarship from GlaxoSmithKline for a student under the supervision of AM. JM is an employee of the Pharmaceutical Society of Australia. BM receives royalties for the development of an opioid risk prediction tool which is unrelated to the current study protocol. CAS hold grants from Australia’s National Health and Medical Research Council, and Medical Research Future Fund. CM holds several research grants and a research fellowship from the National Health and Medical Research Council (NHMRC); and several grants from the Medical Research Future Fund (MRFF). Both the NHMRC and MRFF are Australian Government medical research funding agencies. He has received research grants from New South Wales Health, Ramsay Hospital Research Foundation, HCF Research Foundation, Arthritis Australia, Australian Rheumatology Association, and Royal Prince Alfred Hospital. His travel expenses have been covered when he has been an invited speaker at a scientific conference.
